This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Recombinant Mouse B-cell Receptor CD22 (CD22), C-His
Product Overview
BioVenic's Recombinant Mouse B-cell Receptor CD22 (CD22), C-His is a recombinant protein expressed from Human Cells. Its predicted molecular weight is 97.1 kDa. The purity is>90%.
Specifications
Target Information
Mouse B-cell Receptor CD22 (CD22) is a sialic acid-binding immunoglobulin-type lectin expressed on B cells. It functions as an inhibitory receptor, regulating B cell activation and preventing autoimmunity. CD22 binds to sialic acid-containing ligands on other cells, modulating B cell responses. This receptor plays a role in maintaining immune tolerance and preventing excessive B cell activation. CD22 has been targeted in therapies for B cell malignancies, such as certain types of leukemia and lymphoma.
Shipping and Storage
This product is shipped with ice packs. Lyophilized protein can be stored at -20°C for 1 year. After reconstitution, the protein solution can be stored at 2-8°C for 2-7 days.
Documents
The product is for research use only.
Not for commercial, prophylactic, diagnostic, or therapeutic applications.
User Note
- Always centrifuge tubes before opening. Avoid mixing by vortexing or pipetting. Aliquot the reconstituted solution to minimize freeze-thaw cycles.